/
Corporate Overview We are a U.S. holding company primarily operating through our wholly owned subsidiary, Platinum International Biotech Co., Ltd., a company organized under the laws of the Cayman Islands ( Platinum ). Platinum is not a Chinese operating company but a Cayman Islands holding company, which in turn operates in China through its subsidiaries and contractual arrangements with a var…
The business is unprofitable at the operating level (-9614.64% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue up 256.0% YoY with margins expanding 41391.7pp.
ROIC dropped from -321.18% to -336.57%, capital efficiency is deteriorating. Negative free cash flow of -$843K. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (TTM)
$12K
▲ +256.0% YoY
Net Income (TTM)
-$885K
▲ +39.2% YoY
Op. Margin
-8173.49%
▲ +41391.7pp YoY
ROIC
-722.67%
▼ -15.4pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$658K
▲ +37.0% YoY
Op. Cash Flow (TTM)
-$658K
▲ +37.0% YoY
Net Debt
$29K
Cash & Equiv.
$10K
Continue Research